Revealed: US Intravenous Immunoglobulin Market Share to Experience Steady Growth Through 2035
The US intravenous immunoglobulin market is on track to see an increase in market share, expanding from $2.7 billion in 2024 to an estimated $4.05 billion by 2035. Contributing to this growth is a compound annual growth rate (CAGR) of 3.75%, indicating strong demand for immunoglobulin therapies across various healthcare applications. The increasing prevalence of autoimmune disorders has created...
0 Commentarios 0 Acciones 9 Views 0 Vista previa